more information

Category:

Biologically Active Peptides

reference

1. R.L. Haberl, P.J. Decker, and K.M. Einhäupl, Circ. Res., 68, 1621 (1991). (Biological Activity)
2. J.W. Harding, V.I. Cook, A.V. Miller-Wing, J.M. Hanesworth, M.F. Sardinia, K.L. Hall, J.W. Stobb, G.N. Swanson, J.K.M. Coleman, J.W. Wright, and E.C. Harding, Brain Res., 583, 340 (1992). (Specific Binding Site in Brain)
3. J.M. Hanesworth, M.F. Sardinia, L.T. Krebs, K.L. Hall, and J.W. Harding, J. Pharmacol. Exp. Ther., 266, 1036 (1993). (Specific Binding Site in Heart)
4. M. de Gasparo, A. Husain, W. Alexander, K.J. Catt, A.T. Chiu, M. Drew, T. Goodfriend, J.W. Harding, T. Inagami, and P.B.M.W.M. Timmermans, Hypertension, 25, 924 (1995). (AT₄ Receptor; Non AT_1/2 Recognition, Nomenclature)
5. Handbook of Experimental Pharmacology, Angiotensin, (I.H. Page and F.M. Bumpus, eds.), Springer-Verlag, Berlin, Vol. 37, (1974). (Review)
6. M.J. Peach, Physiol. Rev., 57, 313 (1977). (Review)